Simulations mandatory [Two-Stage / GS Designs]

posted by Helmut Homepage – Vienna, Austria, 2024-01-09 10:31 (369 d 14:03 ago) – Posting: # 23824
Views: 6,859

Hi Achievwin,

❝ Thank you for your nice reply.

Welcome.

Just to be clear: Some authors (right now I’m reviewing a manuscript submitted to Stat Med…) believe (‼) that Pocock’s \(\small{\color{Blue}{\alpha_\text{adj}=0.0294}}\) (94.12% CI) is ‘uni­versally’ valid – even for reference-scaling of HVDs. This is a gross misunderstanding and not even wrong. It was derived for superiority testing in a GSD (fixed sample size N) with one interim at – exactly – N/2 and known variances. The fact that it controlled the Type I Error in Pot­vin’s Method B (TSD in a 2×2×2 design) was a mere lucky punch.
In my example I needed \(\small{\color{Red}{\alpha_\text{adj}=0.0274}}\) (94.52% CI) to control the Type I Error.

Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

UA Flag
Activity
 Admin contact
23,359 posts in 4,905 threads, 1,671 registered users;
109 visitors (0 registered, 109 guests [including 18 identified bots]).
Forum time: 00:35 CET (Europe/Vienna)

Trust, but verify.    Anonymous (Russian proverb)

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5